Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer.

Ridnour LA., Heinz WF., Cheng RYS., Wink AL., Kedei N., Pore M., Imtiaz F., Femino EL., Gonzalez AL., Coutinho LL., Moffat RL., Butcher D., Edmondson EF., Li X., Rangel MC., Kinders RJ., Rittscher J., Lipkowitz S., Wong STC., Anderson SK., McVicar DW., Glynn SA., Billiar TR., Chang JC., Hewitt SM., Ambs S., Lockett SJ., Wink DA.

SignificanceThis work identifies CD8-NOS2+COX2+ and CD8-NOS2-COX2+ unique cellular neighborhoods that drive the tumor immune spatial architecture of CD8+ T cells predictive of clinical outcome and can be targeted with clinically available NOS inhibitors and NSAIDs.

More information Original publication

DOI

10.1158/2767-9764.crc-24-0235

Type

Journal article

Publication Date

2024-10-01T00:00:00+00:00

Volume

4

Pages

2766 - 2782

Total pages

16

Addresses

C, a, n, c, e, r, , I, n, n, o, v, a, t, i, o, n, , L, a, b, o, r, a, t, o, r, y, ,, , C, e, n, t, e, r, , f, o, r, , C, a, n, c, e, r, , R, e, s, e, a, r, c, h, ,, , N, a, t, i, o, n, a, l, , C, a, n, c, e, r, , I, n, s, t, i, t, u, t, e, ,, , N, a, t, i, o, n, a, l, , I, n, s, t, i, t, u, t, e, s, , o, f, , H, e, a, l, t, h, ,, , F, r, e, d, e, r, i, c, k, ,, , M, a, r, y, l, a, n, d, .

Keywords

CD8-Positive T-Lymphocytes, Animals, Humans, Mice, Breast Neoplasms, Neoplasm Metastasis, Receptors, Estrogen, Female, Cyclooxygenase 2, Nitric Oxide Synthase Type II, Neoplastic Stem Cells, Stem Cell Niche, Tumor Microenvironment